Both Mafron and Eusemide are short-acting birth control pills, and Eusemide is relatively better than Mafron. This is because both Mafolone and Eusemide are combined estrogen and progestin pills. In clinical practice, they can be taken orally from the fifth day of menstruation, once/day, 1 tablet/time, for 21 days, to prevent pregnancy for one month. However, the progestogen in Eusemide is Drospirenone, which can counteract the water and sodium retention caused by estrogen, and will not lead to weight gain and fattening, and the side effects of Eusemide are less than those of Mafron, which often causes weight gain after oral administration in clinical practice. Both Eusemide and Mafron can cause irregular menstruation and irregular vaginal bleeding after oral administration in clinical practice.